Latest Breaking News On - Citius pharma - Page 4 : comparemela.com

Citius Pharmaceuticals and TenX Keane set to form Citius Oncology in 2024

A transaction between Citius Pharmaceuticals and TenX Keane which will result in the formation of Citius Oncology, Inc. is due to close in the first half of next year (2024).

Leonard mazurCitius pharmaCitius pharmaceuticalsDrug administrationTenx keaneCitius oncologyBiologics license applicationXiaofeng yuanMergers and acquisitionsMergers and acquisitionsCitius pharmaceuticalsRare diseaseOrphan disease

Citius Pharmaceuticals Announces Publication in Frontiers of Immunology of Positive Results from Solid Tumor Study of LYMPHIR™ in Combination with Checkpoint Inhibitor

Citius Pharmaceuticals Announces Publication in Frontiers of Immunology of Positive Results from Solid Tumor Study of LYMPHIR™ in Combination with Checkpoint Inhibitor
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Citius pharmaLeonard mazurGreg salsburgMyron czuczmanIlanit allenExchange commissionCompany nasdaqUniversity of pittsburghCitius pharmaceuticals incUniversity of minnesotaPrnewswire citius pharmaceuticals incSecurities exchangeHillman cancer centerUniversity of pittsburgh medical centerMasonic cancer centerChief medical officer

Citius Pharma sets sights on $675M merger deal

Citius Pharma sets sights on $675M merger deal
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCitius pharmaMyron czuczmanCitius pharma leonard mazurJaime bartushakMyron holubiakCitius pharmaceuticals incCrone law groupCitius oncology incDrug administrationNewbridge securities corpMaxim groupWyrick robbins yates pontonCitius pharmaceuticalsTenx keane acquisition

Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc

Citius Pharmaceuticals, Inc. to receive $675 million in equity of Citius Oncology, Inc. and retain approximately 90% majority control in publicly listed Citius Oncology, Inc. post.

United statesNew yorkNew jerseyJaime bartushakIlanit allenTaylor zhangMyron holubiakCitius pharmaGreg salsburgMyron czuczmanLeonard mazurDrug administrationSecurities exchangeWyrick robbins yates pontonExchange commissionMaxim group

Citius Pharmaceuticals (CTXR) to Merge Wholly Owned Subsidiary with TenX Keane Acquisition (TENK) to Form Publicly Listed Citius Oncology, Inc

Citius Pharmaceuticals (CTXR) to Merge Wholly Owned Subsidiary with TenX Keane Acquisition (TENK) to Form Publicly Listed Citius Oncology, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Citius pharmaCitius pharmaceuticals incCompany nasdaqCitius pharmaceuticals